1. Home
  2. CDZI vs CLLS Comparison

CDZI vs CLLS Comparison

Compare CDZI & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDZI
  • CLLS
  • Stock Information
  • Founded
  • CDZI 1983
  • CLLS 1999
  • Country
  • CDZI United States
  • CLLS France
  • Employees
  • CDZI N/A
  • CLLS N/A
  • Industry
  • CDZI Water Supply
  • CLLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CDZI Utilities
  • CLLS Health Care
  • Exchange
  • CDZI Nasdaq
  • CLLS Nasdaq
  • Market Cap
  • CDZI 257.9M
  • CLLS 299.0M
  • IPO Year
  • CDZI N/A
  • CLLS 2007
  • Fundamental
  • Price
  • CDZI $5.26
  • CLLS $3.27
  • Analyst Decision
  • CDZI
  • CLLS Buy
  • Analyst Count
  • CDZI 0
  • CLLS 1
  • Target Price
  • CDZI N/A
  • CLLS $8.00
  • AVG Volume (30 Days)
  • CDZI 1.1M
  • CLLS 179.7K
  • Earning Date
  • CDZI 11-13-2025
  • CLLS 11-07-2025
  • Dividend Yield
  • CDZI N/A
  • CLLS N/A
  • EPS Growth
  • CDZI N/A
  • CLLS N/A
  • EPS
  • CDZI N/A
  • CLLS N/A
  • Revenue
  • CDZI $15,054,000.00
  • CLLS $63,438,000.00
  • Revenue This Year
  • CDZI $58.18
  • CLLS N/A
  • Revenue Next Year
  • CDZI $32.89
  • CLLS $66.76
  • P/E Ratio
  • CDZI N/A
  • CLLS N/A
  • Revenue Growth
  • CDZI 460.46
  • CLLS 223.09
  • 52 Week Low
  • CDZI $2.13
  • CLLS $1.10
  • 52 Week High
  • CDZI $6.10
  • CLLS $5.48
  • Technical
  • Relative Strength Index (RSI)
  • CDZI 54.04
  • CLLS 42.27
  • Support Level
  • CDZI $4.64
  • CLLS $3.43
  • Resistance Level
  • CDZI $5.88
  • CLLS $3.79
  • Average True Range (ATR)
  • CDZI 0.36
  • CLLS 0.33
  • MACD
  • CDZI -0.05
  • CLLS -0.10
  • Stochastic Oscillator
  • CDZI 42.47
  • CLLS 4.51

About CDZI CADIZ Inc.

Cadiz Inc is a water solutions provider, dedicated to delivering clean, reliable, and affordable water for people. It provides water solutions with a combination of land, water, pipeline, and water filtration assets located in Southern California between key water systems serving population centers in the Southwestern United States. The company operates in two reportable segments; Land and Water Resources segment, which derives key revenue, and comprises all activities regarding its properties in the eastern Mojave Desert, pre-revenue development of the Mojave Groundwater Bank (supply, storage, and conveyance), and agricultural operations; and the Water Filtration Technology segment, which provides water filtration solutions for impaired or contaminated groundwater sources.

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

Share on Social Networks: